Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

HLA‐DPB113:01 associates with enhanced, and KIR2DS4001 with diminished protection from developing severe COVID‐19

HLA(2023)10.1111/tan.15251Source: DataRank Database

HLA‐DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID‐19 is a research paper published in HLA (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

refsnp uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.38)OA: hybridTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Silvia Brugiapaglia ORCID,Susanna Croci ORCID,Paola Magistroni,Claudia Curcio ORCID,Kristina Zguro ORCID

Live enrichment

PubMed:37850268 PMC:PMC10873037 OpenAlex:https://openalex.org/W4387728529

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Grant: 201608/2019‐7

National Institutes of Health

Grant: R01 AI158410

Telethon

Grant: GTB18001

FWCI

1.38

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tan.15251

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tan.15251

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/tan.15251

journalhttps://doi.org/10.1111/tan.15251

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37850268

Fields of Study

Immune Cell Function and InteractionCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

MeSH Terms

COVID-19SARS-CoV-2AllelesAutoantibodiesGenotypeHumansReceptors, KIRHLA-DP beta-Chains

Keywords

AllotypeImmunologyHuman leukocyte antigenAutoantibodyAntibodyGenotypeMedicineBiologyInternal medicineAntigenGeneticsGeneHla Class IiHla-dpb1Kir2ds4Covid-19Ifn-α Antibodies

Sustainable Development Goals

SDG 0: Good health and well-being

HLA‐DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID‐19

FAIR Checklist

Authors (24)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

HLA‐DPB113:01 associates with enhanced, and KIR2DS4001 with diminished protection from developing severe COVID‐19